期刊论文

Wang, M.Q.

中文

中国中西医结合杂志

1003-5370

2003

23

12

902-904

10.3321/j.issn:1003-5370.2003.12.006

湖南省科技厅资助科研课题 （No .2 30 1 7）；

本校为第一机构

目的:观察截哮口服液防治病毒诱发小儿哮喘的疗效及可能的作用机理.方法:将160例有哮喘史的病毒性上呼吸道感染患儿随机分为两组.治疗组患儿在出现急性上呼吸道感染(AURTI)症状24h内服用截哮口服液,对照组使用病毒唑10～15mg·kg-1·d-1,疗程均为7日,并观察患儿临床体征、疗效,检测肺功能、免疫球蛋白等的变化.结果:治疗组总有效率83.8%,临床控制率48.8%,与对照组(分别为62.5%、23.8%)比较,差异均有显著性(P＜0.01).截哮口服液对患儿FEV1、PEF有明显改善作用,与治疗前比较,差异有显著性(P＜0.01),与对照组比较,差异亦有显著性(P＜0.05).治疗组自身前后对照及与对照组治疗后比较IgE降低,差异均有...

OBJECTIVE: To observe the effect and the possible mechanism of Jiexiao Oral Liquid (JXOL) in preventing and curing virus induced asthma in children. METHODS: One hundred and sixty patients of acute upper respiratory tract infection (AURTI) with asthma history were randomly divided into 2 groups. JXOL was given to the treated group within 24 hrs after occurrence of AURTI symptoms, and virazole of 10-15 mg.kg-1.d-1 was given to the control group, the therapeutic course for both groups was 7 days. Changes of clinical symptoms, signs, therapeutic effect, pulmonary function and immuno-globulin in p...